Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma

Clinical trial NCT01649830 · RECRUITING

Trial details

NCT number: NCT01649830
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Astrocytoma Oligodendroglioma Oligodendroastrocytoma

Start date: 2012-07-01
Primary completion: 2025-08-01
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.